Our guts are inhabited by an enormous number of commensal bacteria, commonly referred to as the gut microbiota. Complex host-gut microbiota interactions are involved in the formation of the unique "gut ecosystem". This ecosystem is thought to play a variety of roles in host physiology and pathology, including the modification and shaping of the host immune system. We have proposed an integrated omics approach for a comprehensive understanding of the gut ecosystem, where different levels of cyclopedic analyses, such as (meta)transcriptome and metabolome, are combined with the metagenome. Using this approach, we have discovered the mechanism by which the gut microbiota-derived short-chain fatty acid acetate protects mice from enterohemorrhagic Escherichia coli O157-infectious death. We have also shown that butyrate produced by the gut microbiota promotes differentiation of peripherally derived regulatory T cells in colonic lamina propria through epigenetic modification. In this minireview, I will discuss recent advances in our understanding of the role of gut microbial short-chain fatty acids in host defense and immune regulation, focusing mainly on results from our laboratory.
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As such, the gut microbiota is in some ways like an organ, possessing its own metabolic system, often described as comparable to that of the liver, and it forms a unique and complex gut ecosystem by interacting with the host. The gut ecosystem is thought to play a variety of roles in host physiology and pathology, including the modification and shaping of the host immune system. .
In this minireview, I will discuss recent advances in our understanding of the role of gut microbial short-chain fatty acids (SCFAs) in host defense and immune regulation, focusing mainly on results from our laboratory. .
Acetate can protect from death due to enterohemorrhagic Escherichia coli infection
Prior association of GF mice with certain strains of Bifidobacterium protects them from subsequent O157-infectious death 10) . There are no differences between the mice colonized with "protective" and "non-protective"
Bifidobacterium strains in terms of the number of O157 bacteria, the concentration of fecal Shiga toxin, the amount of mucin, or the pH of their feces. However, the serum concentration of Shiga toxin was significantly elevated in mice harboring the non-protective strain, reaching a lethal level, while it remained very low in mice with the protective strain 5)
.
Histological examination revealed that in the non-protective strain-associated mice apoptosis of the epithelium was modestly increased only in the most distal part of colon, accompanied by a weak inflammation, as early as one day after O157 oral infection. By contrast, no difference was observed between infected and non-infected protective strain-associated mice in the apoptotic cell number, i.e.
there were only a small number of apoptotic cells on the mucosal surface resulting from physiological epithelial turnover 5)
. . Of note, both protective and nonprotective strains produce equivalent amounts of acetate in vitro when glucose instead of fructose is used as the carbon source. This is consistent with the fact that glucose is abundant in the cecum but barely detectable in the feces of mice associated with both protective and non-protective strains, whereas fructose is readily detected even in the feces of these mice. The differential distribution of these carbohydrates is consistent with our finding that the slight gut inflammation in non-protective strain-associated mice upon O157 infection is only observed in the distal colon but not in the cecum. This is likely due to the production of sufficient acetate from glucose to prevent epithelial cell apoptosis in the cecum by both protective and nonprotective strains but, by contrast, only the protective strains, which possess fructose transporters, can produce enough protective acetate from fructose in the distal colon (Fig. 2) . .
The pTregs are especially abundant in the intestine and exogenous antigens are thought to be important for their differentiation, since the number of colonic pTregs is reduced in GF compared to conventional mice 16) . It has been shown by Kenya Honda's group that a mixture of bacteria belonging to class Clostridia both from murine 16) and human 17) feces can augment colonic pTregs in GF mice.
The cecum of GF mice is distended because of the . Furthermore, colonic pTregs were increased in mice fed butyrylated high-amylose maize starch 12) (HAMSB), suggesting that butyrate can enhance the differentiation of colonic pTregs (Fig. 3) .
How then does butyrate enhance pTreg differentiation?
Butyrate is a well-known potent inhibitor of histone deacetylases (HDACs) 19, 20) , which negatively regulate transcription through a specific epigenetic modification, deacetylation of lysine residues in the C-terminal histone tail 20) . . That the histone acetylation was only observed in a subset of chromatin regions is consistent with the notion that HDAC inhibition generally affects the expression level of as few as -2% of total genes 20) . The limited effect of butyrate on histone acetylation observed . Thus, butyrate can enhance Treg induction by epigenetic regulation of Foxp3 transcription (Fig. 3) . HDACs catalyze the removal of acetyl functional groups from the lysine residues of both histone and non-histone proteins 21) .
Foxp3 itself is known to be acetylated and, as a result, stabilized to exert enhanced function 22) . Indeed, a higher
Foxp3 protein level per cell was observed in butyratetreated compared to non-treated CD4 + T cells 23) . In addition to its direct effect on CD4 + T cells, indirect effects of butyrate have also been reported; e.g., butyrate-pretreatment confers dendritic cells with an enhanced Treg differentiation ability, probably also via HDAC inhibition 23) (Fig. 3) .
G-protein-coupled receptors (GPRs) such as GPR41 24) , GPR43 25, 26) and GPR109A 27) have also been reported to sense SCFAs and to exert immunomodulatory functions.
However, studies using mice deficient for these GPRs exclude their possible involvement in butyrate-mediated colonic pTreg differentiation 23, 28) .
Colonic to maintain immune homeostasis in the gut (Fig. 3) . The effect of butyrate in the containment of colitis in mice is consistent with observations in human inflammatory bowel disease (IBD). For example, the concentration of butyrate 31) and butyrate-producing bacteria 32, 33) are decreased in IBD.
In addition, butyrate enema has been reported to have anti-inflammatory effects in patients with the IBD ulcerative colitis 34, 35) .
Suppressive regulation of colonic macrophages by microbial butyrate
Macrophages are the most abundant immune cells in colonic lamina propria 36) . Macrophages in the colon are different from those in the other tissues in that they are more anti-inflammatory, with a lower sensitivity to TLR ligand stimulation 37) . This hyposensitivity to TLR signaling has been reported to be due to epigenetic regulation through HDAC inhibition by microbial butyrate 38) . Of interest, in this case enhanced lysine acetylation of histone H3 in the promoter region of genes encoding pro-inflammatory cytokines IL-6 and IL-12 recruits Mi-2β, a component of the Mi-2/NuRD repressor complex, which results in the decreased expression of these cytokines 38) .
Immunoregulatory functions of SCFAs via GPR43
Gut microbiota-derived acetate has also been reported to exert a systemic anti-inflammatory effect 39) . Oral administration of dextran sulphate sodium (DSS) in mice induces a colitis resembling human ulcerative colitis 40) , and this colitis is exacerbated in GF mice 39) . Acetate in the drinking water prevented this exacerbation and, concomitantly, levels of the pro-inflammatory cytokine TNFα and the neutrophil inflammation mediator myeloperoxidase decreased in the colonic tissue. GPR43-deficient mice suffered from exacerbated DSS colitis similar to GF mice, but in this case oral acetate did not ameliorate the disease, indicating that the effect of acetate is mediated by GPR43. Of note, inflammations outside of the intestine, such as in experimental arthritis and asthma, becomes more severe in GF, as well as GPR43-deficient, mice, and these inflammations in GF mice can also be ameliorated with acetate in drinking water. GPR43 has previously Special Issue (Mini Review) Short-chain fatty acids in host defense and immunity been reported to act as a chemoattractant receptor for neutrophils 41) . Maslowski et al. observed that acetate was both a chemoattractant as well a potent inducer of neutrophils apoptosis 39) . Acetate is rapidly absorbed from the intestinal lumen into the bloodstream 42) and therefore could act systemically on neutrophils to retain them in the vascular system and to induce apoptosis, which would suppress peripheral inflammatory responses.
It has also been reported that supplementation of drinking water with acetate and propionate, but not butyrate, recruits already existing systemic tTregs to the intestine through GPR43 expressed on tTregs by upregulating the expression of GPR15 43) , an orphan receptor that plays a role in gut homing 44) . This observation is consistent with the notion that orally administered SCFAs are mostly absorbed in the small intestine before arriving in the colon, thus exerting a systemic effect rather than acting on the colonic tissue 42) ,
and that butyrate is a weaker agonist than acetate and propionate for GPR43 45) .
Conclusion
As highlighted in this brief review, SCFAs exert a range of functions in immune and inflammatory responses by acting on diverse cell populations using several different mechanisms. Our knowledge on the functions of SCFAs is still quite limited, but comprehensive understanding of the roles of SCFAs in our physiology should allow us to utilize a combination of microbes and SCFAs for preventive and therapeutic use in the future.
